Sally Leong
Internal Medicine · Sylmar, CANPI 1801478532
Payments from drug & device makers
Across 49 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$446
- Astellas Pharma US Inc$200
- AstraZeneca$164
- Daiichi Sankyo Inc.$127
- Sun Pharmaceutical Industries Inc.$122
- Merck$114
- plus $590 from 15 others
What the payments were for
- Food & beverage$1,48884%
- Education$27516%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 10 | $446 |
| Astellas Pharma US Inc | 2 | $200 |
| AstraZeneca(2 entities) | 7 | $164 |
| Daiichi Sankyo Inc. | 3 | $127 |
| Sun Pharmaceutical Industries Inc. | 1 | $122 |
| Merck | 4 | $114 |
| Johnson & Johnson | 3 | $91 |
| Genentech USA, Inc. | 3 | $73 |
| Lilly USA, LLC | 2 | $65 |
| Bristol Myers Squibb | 2 | $59 |
| Incyte Corporation | 2 | $52 |
| Geron Corporation | 1 | $31 |
| Genmab U.S., Inc. | 1 | $30 |
| Eisai Inc. | 1 | $28 |
| Pfizer | 1 | $27 |
| Novartis | 1 | $24 |
| Sanofi | 1 | $24 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $22 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,763 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $10,673 |
| Omeprazole | 11 | $168 |
| Metformin Hcl | 15 | $132 |
| Atorvastatin Calcium | 19 | $99 |
| Lisinopril | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Sylmar
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.